Cohen, BE
Edwin Cohen, Antwerp BE
Patent application number | Description | Published |
---|---|---|
20150219424 | ARMOR SYSTEM - An armor system pellet is provided. The pellet includes a pellet body attached to four projections for interlocking adjacent pellets when arranged in an array. The pellet is configured such that the width of a first pair of co-linear projections is less than a width of a second pair of co-linear projections. | 08-06-2015 |
Joe D. Cohen, Brussels BE
Patent application number | Description | Published |
---|---|---|
20100028386 | RECOMBINANT P. FALCIPARUM MEROZOITE PROTEIN-142 VACCINE - In this application is described the expression and purification of a recombinant | 02-04-2010 |
Joseph Cohen, Brussels BE
Patent application number | Description | Published |
---|---|---|
20100204458 | Process for the Production of Immunogenic Compositions - The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3. | 08-12-2010 |
20100209444 | MAGE3 Polypeptides - The present invention relates to novel MAGE3 polypeptides, including a fragment of MAGE3 fused to an immunological fusion partner, and compositions thereof. | 08-19-2010 |
20120269835 | PROCESS FOR THE PRODUCTION OF IMMUNOGENIC COMPOSITIONS - The present invention relates to a process for producing immunogenic polypeptides, comprising reducing disulfide bonds and blocking the resulting free thiol group with a blocking agent. The immunogenic peptides comprise a fragment of MAGE A3. | 10-25-2012 |
Joseph Cohen, Rixensart BE
Patent application number | Description | Published |
---|---|---|
20090191234 | VACCINE - This invention relates to three newly-identified, distinct groups of antigenic peptides [LB1(f) peptides] from the same region of the P5-like fimbrin protein discovered using sequence data from the fimbrin protein of many | 07-30-2009 |
Joseph D. Cohen, Rixensart BE
Patent application number | Description | Published |
---|---|---|
20080317787 | Anti-Malaria Vaccine - There is provided, inter alia, a method for the prophylaxis of productive malaria infection in travelers to endemic regions comprising the administration of suitable amounts of a formulation comprising a | 12-25-2008 |
20100062028 | VACCINES FOR MALARIA - The present invention relates to a novel hybrid/fusion protein derived from the CS protein of | 03-11-2010 |
20100150998 | VACCINES FOR MALARIA - The present invention relates to a novel lipoprotein particle, methods for preparing and purifying the same, its use in medicine, particularly in the prevention of malarial infections, compositions/vaccines containing the particle or antibodies against the protein particle such as monoclonal or polyclonal antibodies and use of the same, particularly in therapy. In particular it relates to an immunogenic protein particle comprising the following monomers: | 06-17-2010 |
20100272786 | VACCINE - The invention relates to a replication deficient simian adenoviral vector C7 encoding a protein comprising CS protein from | 10-28-2010 |
20100272788 | VACCINES FOR MALARIA - The present invention relates to a novel lipoprotein particle, methods for preparing and purifying the same, its use in medicine, particularly in the prevention of malarial infections, compositions/vaccines containing the particle or antibodies against the protein particle such as monoclonal or polyclonal antibodies and use of the same, particularly in therapy. Furthermore, particles with the specific ratio can be prepared by employing yeast, | 10-28-2010 |
20110212159 | VACCINES - The invention relates to use of an antigen derived from the circumsporozoite protein (CS) protein of | 09-01-2011 |
20120014994 | Malaria prime/boost vaccines - Described are vaccine regimens in which specific prime/boost regimens are applied using low-neutralized recombinant adenoviral vectors harboring nucleic acids encoding antigens from | 01-19-2012 |